Does APIXABAN Cause Epistaxis? 2,831 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 2,831 reports of Epistaxis have been filed in association with APIXABAN (ELIQUIS). This represents 1.8% of all adverse event reports for APIXABAN.
2,831
Reports of Epistaxis with APIXABAN
1.8%
of all APIXABAN reports
152
Deaths
895
Hospitalizations
How Dangerous Is Epistaxis From APIXABAN?
Of the 2,831 reports, 152 (5.4%) resulted in death, 895 (31.6%) required hospitalization, and 119 (4.2%) were considered life-threatening.
Is Epistaxis Listed in the Official Label?
Yes, Epistaxis is listed as a known adverse reaction in the official FDA drug label for APIXABAN.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
FLUTICASONE (1,745)
TREPROSTINIL (1,726)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
PALBOCICLIB (1,280)
ADALIMUMAB (1,243)
METHOTREXATE (1,108)
Which APIXABAN Alternatives Have Lower Epistaxis Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ